Related Experiment Videos
Spinal chondrosarcoma demonstrated by Tc-99m-MDP bone scan.
Clinical Nuclear Medicine
|March 1, 1982
Summary
A bone scan effectively identified a spinal chondrosarcoma and its full extent in a 45-year-old woman. This noninvasive technique is recommended for preoperative assessment of chondrosarcoma tumor staging.
Area of Science:
- Orthopedic Oncology
- Diagnostic Imaging
- Nuclear Medicine
Background:
- Chondrosarcoma, a malignant tumor of cartilage, can occur in the spine, posing diagnostic challenges.
- Accurate tumor staging is crucial for effective treatment planning and surgical management of spinal tumors.
Observation:
- A case study details a 45-year-old female patient diagnosed with chondrosarcoma of the spine.
- Diagnostic imaging included a bone scan following the intravenous administration of Technetium-99m-labeled methylene diphosphonate (Tc-99m-MDP).
Findings:
- The bone scan confirmed the tumor was solitary.
- The scan precisely delineated the tumor's extent within the spinous process of the second dorsal vertebra.
- Tc-99m-MDP bone scintigraphy proved valuable in visualizing the spinal chondrosarcoma.
Implications:
- Preoperative bone scintigraphy is a safe and noninvasive method for assessing the extent of spinal chondrosarcoma.
- This technique aids in surgical planning and improves patient outcomes for spinal chondrosarcoma.
- Bone scans are essential for evaluating the full scope of chondrosarcoma before surgical intervention.